Tumor necrosis factor (TNF) inhibitors represent one of the most successful biologic therapies for RA, with drugs such as adalimumab, etanercept, and infliximab demonstrating significant efficacy in reducing inflammation and preventing joint damage. Here, TNF is linked to rheumatoid arthritis.